These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2141295

  • 1. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F, Pollard RB, Uchimura S, Munakata T, Maeda H.
    Cancer Res; 1990 Jul 01; 50(13):3897-904. PubMed ID: 2141295
    [Abstract] [Full Text] [Related]

  • 2. Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F, Munakata T, Maeda H.
    Anticancer Res; 1988 Jul 01; 8(1):97-103. PubMed ID: 2451896
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.
    Suzuki F, Pollard RB, Maeda H.
    Cancer Immunol Immunother; 1989 Jul 01; 30(2):97-104. PubMed ID: 2480846
    [Abstract] [Full Text] [Related]

  • 4. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
    Suzuki F, Okuno Y, Maeda Y, Maeda H.
    Gan To Kagaku Ryoho; 1987 Dec 01; 14(12):3305-12. PubMed ID: 2961306
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
    Schmitt DA, Kisanuki K, Kimura S, Oka K, Pollard RB, Maeda H, Suzuki F.
    Anticancer Res; 1992 Dec 01; 12(6B):2219-24. PubMed ID: 1295469
    [Abstract] [Full Text] [Related]

  • 6. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM, Tang JC, DeLong DC, Ades EW, Altom MG.
    Cancer Res; 1986 Nov 01; 46(11):5624-8. PubMed ID: 3756909
    [Abstract] [Full Text] [Related]

  • 7. Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation.
    Suzuki F, Matsumoto K, Schmitt DA, Pollard RB, Maeda H.
    Int J Immunopharmacol; 1993 Feb 01; 15(2):175-83. PubMed ID: 7682198
    [Abstract] [Full Text] [Related]

  • 8. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 9. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E.
    Cancer Res; 1987 Feb 01; 47(3):809-15. PubMed ID: 3802083
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA, Hiserodt JC, Abruzzo LV, Varani J.
    Cancer Res; 1986 Jul 01; 46(7):3407-12. PubMed ID: 2939945
    [Abstract] [Full Text] [Related]

  • 11. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH, Herberman RB, Zhang SR, Chirigos MA, Ortaldo JR, Green KM, Talmadge JE.
    J Immunol; 1985 Jun 01; 134(6):4267-75. PubMed ID: 3989307
    [Abstract] [Full Text] [Related]

  • 12. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
    Oda T, Sato F, Maeda H.
    J Natl Cancer Inst; 1987 Dec 01; 79(6):1205-11. PubMed ID: 2961908
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
    Oda T, Sato F, Yamamoto H, Akagi M, Maeda H.
    Anticancer Res; 1989 Dec 01; 9(2):261-5. PubMed ID: 2526613
    [Abstract] [Full Text] [Related]

  • 14. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG.
    Shimada S, Yano O, Tokunaga T.
    Jpn J Cancer Res; 1986 Aug 01; 77(8):808-16. PubMed ID: 2428798
    [Abstract] [Full Text] [Related]

  • 15. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T, Sato S, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1986 Aug 01; 77(8):825-32. PubMed ID: 3093429
    [Abstract] [Full Text] [Related]

  • 16. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity.
    Riser BL, Laybourn KA, Varani J.
    Nat Immun Cell Growth Regul; 1988 Aug 01; 7(5-6):305-15. PubMed ID: 3221908
    [Abstract] [Full Text] [Related]

  • 17. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS, Bennett M, Kumar V.
    Nat Immun Cell Growth Regul; 1986 Aug 01; 5(4):200-10. PubMed ID: 2430178
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of macrophage by polyanions and its conjugated proteins and effect on cell membrane.
    Oda T, Morinaga T, Maeda H.
    Proc Soc Exp Biol Med; 1986 Jan 01; 181(1):9-17. PubMed ID: 2935880
    [Abstract] [Full Text] [Related]

  • 19. Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli.
    Suzuki F, Brutkiewicz RR, Pollard RB.
    J Natl Cancer Inst; 1986 Aug 01; 77(2):441-7. PubMed ID: 3090339
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH, Wallace TL, Richard KA, Tracey DE.
    Cancer Res; 1985 Feb 01; 45(2):532-8. PubMed ID: 3967227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.